Science Explorer Interactive view Map
Company · Beijing · China

Astellas Pharma (China)

astellas.com.cnROR OpenAlex
Research works
106
▲ 42% vs 2013–17
Citations
3.3k
31.2 per fractional work
Top-10% rate
17.0%
record average 16.5%
Open access
51%
world 28%

Not ranked overall: Astellas Pharma (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.19× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.52× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 5.34× its world share, 1 worksImmunology and Micro…Neuroscience: 1.29× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.72× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 1.21× its world share, 0 worksChemical EngineeringChemistry: 2.53× its world share, 1 worksChemistryComputer Science: 0.53× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.44× its world share, 0 worksEarth and Planetary …Energy: 0.46× its world share, 0 worksEnergyEngineering: 0.22× its world share, 1 worksEngineeringEnvironmental Science: 0.28× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.60× its world share, 1 worksMaterials ScienceMathematics: 3.75× its world share, 1 worksMathematicsHealth Professions: 0.15× its world share, 0 worksHealth ProfessionsMedicine: 2.56× its world share, 13 worksMedicineVeterinary: 5.54× its world share, 0 worksVeterinaryDecision Sciences: 0.86× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.14× its world share, 1 worksEconomics, Econometr…Psychology: 0.21× its world share, 0 worksPsychologySocial Sciences: 0.08× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.7×. Every wedge is a field page.

Which keywords describe research at Astellas Pharma (China)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Biomarkers, Medicinal Chemistry, Machine Learning, Molecular Docking, Pharmacokinetics, Molecular Dynamics and Tumor Microenvironment.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 15 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 15 words, with their numbers
  1. Machine Learning2▲ 2.5×8 topics
  2. Immunotherapy2▲ 8.9×9 topics
  3. Epidemiology2▲ 1.51×12 topics
  4. Biomarkers2▲ 8.2×4 topics
  5. Medicinal Chemistry1▲ 19×3 topics
  6. Inflammation1▲ 2.4×11 topics
  7. Cardiovascular Disease1▲ 4.1×6 topics
  8. Molecular Docking1▲ 36×2 topics
  9. Pharmacokinetics1▲ 17×2 topics
  10. Quality of Life1▲ 3.1×7 topics
  11. Molecular Dynamics1▲ 25×2 topics
  12. Chemotherapy1▲ 5.6×7 topics
  13. Drug Target Identification1▲ 42×1 topic
  14. Tumor Microenvironment1▲ 8.9×6 topics
  15. Virtual Screening1▲ 42×1 topic

Which research topics does Astellas Pharma (China) publish most on?

By volume in 2022–2025: Computational Drug Discovery Methods, Statistical Methods in Clinical Trials, Machine Learning in Materials Science and Immunotherapy and Immune Responses.

Computational Drug Disco…1Computational Drug Discovery Methods: 1 fractional worksStatistical Methods in C…1Statistical Methods in Clinical Trials: 1 fractional worksMachine Learning in Materials Science: 1 fractional worksImmunotherapy and Immune Responses: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksBladder and Urothelial Cancer Treatments: 0 fractional worksProtein Structure and Dy…0Protein Structure and Dynamics: 0 fractional worksErythropoietin and Anemia Treatment: 0 fractional worksProstate Cancer Treatment and Research: 0 fractional worksHealth Systems, Economic…0Health Systems, Economic Evaluations, Quality of Life: 0 fractional works
Computational Theory and MathematicsStatistics and ProbabilityMaterials ChemistryImmunology6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
  2. 2 Statistical Methods in Clinical Trials Statistics and Probability 1 works
  3. 3 Machine Learning in Materials Science Materials Chemistry 1 works
  4. 4 Immunotherapy and Immune Responses Immunology 1 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 1 works
  6. 6 Bladder and Urothelial Cancer Treatments Surgery 0 works
  7. 7 Protein Structure and Dynamics Molecular Biology 0 works
  8. 8 Erythropoietin and Anemia Treatment Hematology 0 works
  9. 9 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works
  10. 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.8%not open49.2%

World: 28% of research is openly available.

with international co-authors79.5%domestic only20.5%

World: 19% is written across borders.

How has Astellas Pharma (China)'s research output changed?

Output in 2018–2022 was 42% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Beijing

All research institutions in Beijing

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.